Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.66 USD | +2.59% | -0.75% | +41.96% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.96% | 3.89B | |
+26.38% | 49.18B | |
+1.18% | 42.11B | |
+50.30% | 40.37B | |
-5.26% | 28.85B | |
+13.18% | 26.09B | |
-21.99% | 18.71B | |
+8.20% | 13.26B | |
+31.99% | 12.32B | |
+0.15% | 11.99B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Citigroup Initiates Crinetics Pharmaceuticals With Buy Rating, $68 Price Target